HomeOpen Access NewsHealthcare Innovation

Healthcare Innovation

NHS delivers life-changing artificial pancreas to young type 1 diabetics

Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

Moderna and Pfizer vaccines 90% effective in US real-world data

Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.

A healthcare system for the 21st century

Ben Howlett, Managing Director at Public Policy Projects, discusses why we must invest in technology to enable our healthcare systems to reform, and the role of technology in facilitating collaboration between service providers.

Data finds 36% of people refuse COVID vaccine due to side effect fears

According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.

Zebra Technologies: Dedicated to improving global health

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.

Curative approach to severe autoimmune diseases

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

Reconstructive Dentistry: New biomaterials & technologies

Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.

AstraZeneca vaccines made for UK could be kept for EU use only

EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.

Scientists reveal that tinnitus is possible COVID-19 symptom  

The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.

Dexamethasone steroid saved one million people from COVID death

The Dexamethasone steroid has been used across the globe to help treat COVID-19 in the ICU - leading to atleast one million survivors of hospitalisation from the virus.

US trial finds AstraZeneca vaccine 100% effective against COVID death

In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.

Polymers and polymer-based drug delivery in the treatment of dry eye disease

Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.

Poll finds 61% of people in France think AstraZeneca vaccine is unsafe

According to a new YouGov poll, 61% of people in France now believe that the AstraZeneca vaccine is unsafe, with Germany following closely at 55% - creating fears about the potential impact of vaccine hesitancy on the rollout.

COVID-19: The evolution of testing & sequencing

Novacyt Group, discusses the evolution of testing and sequencing during COVID-19 with a panel of distinguished speakers.

Israeli scientists grow mice in artificial wombs outside the body

In a significant breakthrough for life science, Israeli scientists have succeeded in growing mice embryos in artificial wombs - completely outside the body.

Vaccine shortage in UK means under-50s to wait longer for first dose

The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders